10 Trending AI Health Stocks

5. IQVIA Holdings Inc. (NYSE:IQV)

Number of Hedge Fund Holders: 59

IQVIA Holdings Inc. (NYSE:IQV), a leader in healthcare technology, employs AI to streamline clinical trials, accelerate drug development, and analyze healthcare data. Their AI-driven solutions reduce the time needed for drug discovery and improve the efficiency of clinical trials, making them a key player in the healthcare data analytics space.

IQVIA’s financial performance has been strong, with 2023 revenues reaching $14.98 billion, a 4% year-over-year growth. The company’s GAAP net income grew by 24.5%, totaling $1.36 billion. For 2024, IQVIA Holdings Inc. (NYSE:IQV) expects revenues between $15.4 billion and $15.65 billion, signaling continued demand for AI-driven healthcare solutions. Their AI capabilities, particularly in drug development and clinical trial management, are central to this growth.